BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32986846)

  • 41. Emerging roles of N-linked glycosylation in brain physiology and disorders.
    Conroy LR; Hawkinson TR; Young LEA; Gentry MS; Sun RC
    Trends Endocrinol Metab; 2021 Dec; 32(12):980-993. PubMed ID: 34756776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DEAD Box Helicase 24 Is Increased in the Brain in Alzheimer's Disease and
    Axenhus M; Doeswijk T; Nilsson P; Matton A; Winblad B; Tjernberg L; Schedin-Weiss S
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human brain glycoform coregulation network and glycan modification alterations in Alzheimer's disease.
    Zhang Q; Ma C; Chin LS; Pan S; Li L
    Sci Adv; 2024 Apr; 10(14):eadk6911. PubMed ID: 38579000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human-specific features and developmental dynamics of the brain N-glycome.
    Klarić TS; Gudelj I; Santpere G; Novokmet M; Vučković F; Ma S; Doll HM; Risgaard R; Bathla S; Karger A; Nairn AC; Luria V; Bečeheli I; Sherwood CC; Ely JJ; Hof PR; Sousa AMM; Josić D; Lauc G; Sestan N
    Sci Adv; 2023 Dec; 9(49):eadg2615. PubMed ID: 38055821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New insight into protein glycosylation in the development of Alzheimer's disease.
    Zhao J; Lang M
    Cell Death Discov; 2023 Aug; 9(1):314. PubMed ID: 37626031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The multifaceted roles of the brain glycogen.
    Markussen KH; Corti M; Byrne BJ; Vander Kooi CW; Sun RC; Gentry MS
    J Neurochem; 2024 May; 168(5):728-743. PubMed ID: 37554056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Large Scale Screening and Quantitative Analysis of Site-Specific N-Glycopeptides from Human Serum in Early Alzheimer's Disease Using LC-HCD-PRM-MS.
    Pan L; Lin Y; Zhu J; Zhang J; Tan Z; Lubman DM
    J Proteomics Bioinform; 2022; 15(5):. PubMed ID: 37362028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to Alzheimer's disease.
    Tang X; Tena J; Di Lucente J; Maezawa I; Harvey DJ; Jin LW; Lebrilla CB; Zivkovic AM
    Sci Rep; 2023 May; 13(1):7816. PubMed ID: 37188790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of FUT8-catalyzed core fucosylation in Alzheimer's amyloid-β oligomer-induced activation of human microglia.
    Jin LW; di Lucente J; Ruiz Mendiola U; Tang X; Zivkovic AM; Lebrilla CB; Maezawa I
    Glia; 2023 May; 71(5):1346-1359. PubMed ID: 36692036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MS-based glycomics: An analytical tool to assess nervous system diseases.
    Peng W; Kobeissy F; Mondello S; Barsa C; Mechref Y
    Front Neurosci; 2022; 16():1000179. PubMed ID: 36408389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications.
    Azevedo R; Jacquemin C; Villain N; Fenaille F; Lamari F; Becher F
    Cells; 2022 Apr; 11(8):. PubMed ID: 35455959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The dynamic brain N-glycome.
    Klarić TS; Lauc G
    Glycoconj J; 2022 Jun; 39(3):443-471. PubMed ID: 35334027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of N-glycosylation increases amyloidogenic processing of the amyloid precursor protein.
    Lin T; van Husen LS; Yu Y; Tjernberg LO; Schedin-Weiss S
    Glycobiology; 2022 May; 32(6):506-517. PubMed ID: 35275192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Towards Mapping of the Human Brain N-Glycome with Standardized Graphitic Carbon Chromatography.
    Helm J; Hirtler L; Altmann F
    Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bisecting Lewis X in Hybrid-Type
    Helm J; Grünwald-Gruber C; Thader A; Urteil J; Führer J; Stenitzer D; Maresch D; Neumann L; Pabst M; Altmann F
    Anal Chem; 2021 Nov; 93(45):15175-15182. PubMed ID: 34723506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease.
    Bright F; Katzeff JS; Hodges JR; Piguet O; Kril JJ; Halliday GM; Kim WS
    Front Immunol; 2021; 12():736260. PubMed ID: 34539672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abnormal
    Treacy EP; Vencken S; Bosch AM; Gautschi M; Rubio-Gozalbo E; Dawson C; Nerney D; Colhoun HO; Shakerdi L; Pastores GM; O'Flaherty R; Saldova R
    JIMD Rep; 2021 Sep; 61(1):76-88. PubMed ID: 34485021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?
    Gaunitz S; Tjernberg LO; Schedin-Weiss S
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complete spatial characterisation of N-glycosylation upon striatal neuroinflammation in the rodent brain.
    Rebelo AL; Gubinelli F; Roost P; Jan C; Brouillet E; Van Camp N; Drake RR; Saldova R; Pandit A
    J Neuroinflammation; 2021 May; 18(1):116. PubMed ID: 33993882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sialometabolism in Brain Health and Alzheimer's Disease.
    Rawal P; Zhao L
    Front Neurosci; 2021; 15():648617. PubMed ID: 33867926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.